Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Phako-Vitrectomy With ILM Peeling, Retinal Endophotocoagulation, and Intraoperative Use of Bevacizumab for Diffuse Diabetic Macular Edema

NCT01218750 is registered in ClinicalTrials.gov with Military Institute od Medicine National Research Institute as lead sponsor.

NCT NCT01218750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Phako-Vitrectomy With ILM Peeling, Retinal Endophotocoagulation, and Intraoperative Use of Bevacizumab for Diffuse Diabetic Macular Edema
Lead sponsor
Military Institute od Medicine National Research Institute
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2008
Completion date
December 31, 2011
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse diabetic macular edema